Haemolysis risk in methylene blue treatment of G6PD-sufficient and G6PD-deficient West-African children with uncomplicated falciparum malaria: a synopsis of four RCTs

Medications and Glucose-6-Phosphate Dehydrogenase Deficiency

(2010) Ilan Youngster et al.   DRUG SAFETY

The rise and fall of the antimalarial Lapdap: a lesson in pharmacogenetics

(2010) Lucio Luzzatto   LANCET

Consideration of ethics in primaquine therapy against malaria transmission

(2010) J. Kevin Baird et al.   TRENDS IN PARASITOLOGY

Efficacy of methylene blue monotherapy in semi-immune adults with uncomplicated falciparum malaria: a controlled trial in Burkina Faso

(2010) Mamadou Bountogo et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

The Health and Demographic Surveillance System (HDSS) in Nouna, Burkina Faso, 1993–2007

(2010) Ali Sié et al.   Global Health Action

Artemisinin resistance on the Thai–Cambodian border

(2009) Olaf Müller et al.   LANCET

Strong Gametocytocidal Effect of Methylene Blue-Based Combination Therapy against Falciparum Malaria: A Randomised Controlled Trial

(2009) Boubacar Coulibaly et al.   PLoS One

Turquoise to dark green organs at autopsy

(2009) Arne Warth et al.   VIRCHOWS ARCHIV

High absolute bioavailability of methylene blue given as an aqueous oral formulation

(2008) Ingeborg Walter-Sack et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Glucose-6-phosphate dehydrogenase deficiency

(2008) MD Cappellini et al.   LANCET

Safety and Efficacy of Methylene Blue Combined with Artesunate or Amodiaquine for Uncomplicated Falciparum Malaria: A Randomized Controlled Trial from Burkina Faso

(2008) Augustin Zoungrana et al.   PLoS One

High Risk of Severe Anaemia after Chlorproguanil-Dapsone+Artesunate Antimalarial Treatment in Patients with G6PD (A-) Deficiency

(2008) Caterina I. Fanello et al.   PLoS One